Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications

J Zielonka, J Joseph, A Sikora, M Hardy… - Chemical …, 2017 - ACS Publications
Mitochondria are recognized as one of the most important targets for new drug design in
cancer, cardiovascular, and neurological diseases. Currently, the most effective way to …

Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes

S Sarkar, E Malovic, DS Harischandra, HA Ngwa… - Neurotoxicology, 2018 - Elsevier
Chronic manganese (Mn) exposure induces neurotoxicity, which is characterized by
Parkinsonian symptoms resulting from impairment in the extrapyramidal motor system of the …

[HTML][HTML] Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease

MF Yao, T Dang, HJ Wang, XZ Zhu, C Qiao - Behavioural Brain Research, 2024 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss
of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc) and the …

NADPH Oxidase Mediates Membrane Androgen Receptor–Induced Neurodegeneration

MAA Tenkorang, P Duong, RL Cunningham - Endocrinology, 2019 - academic.oup.com
Oxidative stress (OS) is a common characteristic of several neurodegenerative disorders,
including Parkinson disease (PD). PD is more prevalent in men than in women, indicating …

Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses

G Cheng, J Pan, R Podsiadly, J Zielonka… - Free radical biology and …, 2020 - Elsevier
Previous studies have shown that reactive oxygen species (ROS) such as superoxide or
hydrogen peroxide generated at low levels can exert a tumor-promoting role via a redox …

[PDF][PDF] Apocynin as an antidepressant agent: in vivo behavior and oxidative parameters modulation

DP Dalenogare, NS Schiefelbein, MFP Fialho… - academia.edu
Depression is one of the most common mood disorders, which affects one in six people at
some point in life. However, the treatment of this disease is still a challenge. Chronic …

[引用][C] Manuscript in progress; to be submitted to Acta Biomaterialia in 2017

B Schlichtmann, S Ghaisas, R Nelson, M Panthani… - Targeted nano-carriers to …, 2017